Not correct. I want Odac recommendations to be adhered to by the Fda, especially on an unmet need. Not reckless disregard of their own experts. Conditional approval does not prevent a subsequent withdrawal. You talk as if efficacy is disputed? Potency was the red herring given to moat big pharmas profits for a few more years by stalling the advancement of what will prove indisputable science.
2023 The Final Countdown, page-1254
-
- There are more pages in this discussion • 2,150 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.013(0.98%) |
Mkt cap ! $1.467B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $1.348M | 1.048M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 6135 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 35036 | 5 |
View Market Depth
| Last trade - 15.25pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |